<DOC>
	<DOCNO>NCT01233557</DOCNO>
	<brief_summary>Biomarkers bone resorption measure blood patient bone metastasis prostate cancer course illness . Changes biomarkers correlate patient 's treatment antiandrogen therapy bisphosphonates response and/or progression cancer . It hop serial measurement biomarkers may allow therapeutic monitoring future successful individualisation bisphosphonate therapy metastatic prostate cancer .</brief_summary>
	<brief_title>Biomarkers Bone Resorption Metastatic Prostate Cancer</brief_title>
	<detailed_description />
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Bone Resorption</mesh_term>
	<criteria>prostate cancer bone metastases hormone sensitive inadequate renal function ongoing dental problem previous bisphosphonate therapy</criteria>
	<gender>Male</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>November 2015</verification_date>
</DOC>